SEC Form 4 · accession 0000899243-18-029130
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pravin Dugel
Director
Period of report
Oct 26, 2018
Accepted (ET)
Nov 16, 2018 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.05 | Oct 26, 2018 | A | 2,500 | A | — | Oct 26, 2028 | Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1Options fully vest on the date of grant, subject to the director's service on the Board at such time.